Aripiprazole generichealth

País: Nova Zelândia

Língua: inglês

Origem: Medsafe (Medicines Safety Authority)

Ingredientes ativos:

Aripiprazole 15mg

Disponível em:

CARSL Consulting

DCI (Denominação Comum Internacional):

Aripiprazole 15 mg

Dosagem:

15 mg

Forma farmacêutica:

Tablet

Composição:

Active: Aripiprazole 15mg Excipient: Hyprolose Lactose monohydrate Magnesium stearate Maize starch Microcrystalline cellulose

Tipo de prescrição:

Prescription

Fabricado por:

Ind-Swift Laboratories Limited

Indicações terapêuticas:

Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy. Aripiprazole monotherapy is indicated for acute and maintenance treatment of manic and mixed episodes with Bipolar I Disorder with or without psychotic features. Aripiprazole is indicated as an adjunctive therapy to either lithium or valporate for the acute treatment of manic and mixed episodes associated with Bipolar I Disorder with or without psychotic features.

Resumo do produto:

Package - Contents - Shelf Life: Blister pack, Al/Al - 30 tablets - 36 months from date of manufacture stored at or below 30°C

Data de autorização:

2013-05-10